Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
about
Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndromePLK-1 Targeted Inhibitors and Their Potential against TumorigenesisReview: Application of Nanoparticles in Urothelial Cancer of the Urinary BladderSmall activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancerBionanotechnology and the future of glioma.Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growthAdvances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review).The varied roles of nuclear argonaute-small RNA complexes and avenues for therapy.Inducing gene expression by targeting promoter sequences using small activating RNAs.Sprouty genes function in suppression of prostate tumorigenesissaRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcriptionEnhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cellsA New Double Stranded RNA Suppresses Bladder Cancer Development by Upregulating p21 (Waf1/CIP1) Expression.Nanotechnology in bladder cancer: current state of development and clinical practicemiR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Advances in intravesical therapy for urinary tract disorders.Demystifying the mechanistic and functional aspects of p21 gene activation with double-stranded RNAs in human cancer cells.RNA Activation of the Vascular Endothelial Growth Factor Gene (VEGF) Promoter by Double-Stranded RNA and Hypoxia: Role of Noncoding VEGF Promoter TranscriptsPromoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression.Upregulation of RECK gene expression by small double-stranded RNA targeting the promoter region.Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.Development of Therapeutic dsP21-322 for Cancer Treatment.Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells.Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.Small RNA-Guided Transcriptional Gene Activation (RNAa) in Mammalian Cells.RNA activation technique and its applications in cancer research.RNAa and Vector-Mediated Overexpression of DIRAS1 Suppresses Tumor Growth and Migration in Renal Cell Carcinoma
P2860
Q21284684-EB316DD0-A6D9-4FB0-A73B-059A76A3ED7AQ26777811-3CBBFD84-1FFB-484C-A358-C21F4C23B917Q28386921-DF463D86-2DEB-4F03-A983-BE14DD53AC47Q28539229-07A7B6CB-CA82-496E-B871-269FDC24C34FQ30417964-EFE61C51-F0B4-44D9-B2C7-EFE40533B326Q33648752-0A51BD18-A84C-4553-83A8-9FEF209C57FDQ33933049-546A0A55-9795-43B2-B8B0-3C1DC7C208F0Q34440319-F4870847-B9F6-4DF9-A813-9B4AC3FDB201Q34470117-F22754BB-8E8C-4AEA-9F68-43AC43FF25BEQ34476381-2A4A1983-46F6-45A5-B6D4-33C466127700Q34515078-C74B4F02-1AB9-4027-B675-30C35378BB14Q34519820-640233FE-BC22-4AB9-AF87-23EB95273E31Q34582453-4D979137-32D5-4120-9332-81D74B837EA3Q35402181-90B1D586-913D-4F8F-A2DE-9DC02ACF9270Q36036029-D4F694C8-8DB9-41F4-B18C-2335A828009CQ36100381-B7B3044E-2E33-4352-9A63-D17766B0B5E9Q36728287-317505FE-5A14-4411-AC63-0F5418B851CFQ37053829-CAEFF39E-A74C-4EFE-A42D-75AEDCFF977AQ37114371-FF530363-8FEE-4402-AF82-B74B4E9C1F76Q37263325-7F3B5630-FB9E-479B-9B48-C860CD22F9EBQ38786357-AC8EE8A0-695E-4D1A-A32B-9F2FD5D3A72EQ38813869-E340F792-30BB-46A7-A2A3-FEB7A7026C07Q39013440-656D4951-8F6D-4972-9A94-0F43544E61F2Q39128678-70C92980-C5D8-49FA-ACA4-450B9AC3896CQ39390094-B8E864D3-59CD-4468-8BC2-A80E022B0881Q42656489-06354A96-2D45-47EC-99BD-2A373EE50D3EQ47777493-14BCB6D7-39F6-41B9-B0EC-D0836A1D96F9Q49164867-5FA3AD8F-CCE3-4B27-9545-D1F0F43182ABQ49195507-AF4D5ED8-246D-4BE1-8FBB-377B1F5A2658Q50930184-0450CA4E-76C8-4A96-885C-38AF7C6198D4Q55337892-EA4AB64C-754F-4209-96E2-91B2B0B7681FQ58795134-113468D9-0422-4399-928E-C894337B9089
P2860
Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intravesical delivery of small ...... thotopic bladder tumor growth.
@ast
Intravesical delivery of small ...... thotopic bladder tumor growth.
@en
Intravesical delivery of small ...... thotopic bladder tumor growth.
@nl
type
label
Intravesical delivery of small ...... thotopic bladder tumor growth.
@ast
Intravesical delivery of small ...... thotopic bladder tumor growth.
@en
Intravesical delivery of small ...... thotopic bladder tumor growth.
@nl
prefLabel
Intravesical delivery of small ...... thotopic bladder tumor growth.
@ast
Intravesical delivery of small ...... thotopic bladder tumor growth.
@en
Intravesical delivery of small ...... thotopic bladder tumor growth.
@nl
P2093
P1433
P1476
Intravesical delivery of small ...... thotopic bladder tumor growth.
@en
P2093
Hila Epstein-Barash
Klaus Charisse
Long-Cheng Li
Moo Rim Kang
Muthiah Manoharan
Robert F Place
P304
P356
10.1158/0008-5472.CAN-12-1871
P407
P577
2012-08-06T00:00:00Z